Petros Pharmaceuticals, Inc. (PTPI) Balance Sheet
PTPI balance sheet, 2025
December 31, 2025 · U.S. dollars$5.2M assets = $2.3M liabilities + $2.9M equity
Both columns are drawn to the same scale: what PTPI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
PTPI financial health
Descriptive bands, not a rating. Fiscal 2025.
PTPI balance sheet trends, 2018–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $66.9M2018 | $5.2M2025 | −30.6%/yr | |
| Total liabilities | $68.6M2018 | $2.3M2025 | −38.5%/yr | |
| Shareholders’ equity | −$1.7M2018 | $2.9M2025 | — | |
| Cash & short-term investments | $2.8M2018 | $5.1M2025 | +9.1%/yr | |
| Total debt | $47.2M2018 | $7.4M2024 | −26.6%/yr | |
| Net cash (debt) | −$44.4M2018 | −$3.7M2024 | +$40.7M | |
| Working capital | −$22.7M2018 | $2.9M2025 | +$25.6M | |
| Current ratio | 0.412018 | 2.252025 | +1.84 | |
| Debt / equity | 1.712019 | 0.662023 | −1.05 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
PTPI assets
PTPI liabilities and equity
PTPI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
PTPI balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $5.1M | $3.7M | $13.3M | $9.4M | $23.8M | $17.1M | $2.1M | $2.8M |
| Cash & equivalents | $5.1M | $3.7M | $13.3M | $9.4M | $23.8M | $17.1M | $2.1M | $2.8M |
| Short-term investments | — | $3.71B | — | — | — | — | — | — |
| Receivables | $0 | $416,076 | $2.2M | $2.1M | $3.1M | $5.2M | $3.8M | $3.5M |
| Inventory | $0 | $3.0M | $1.6M | $1.8M | $519,649 | $760,530 | $2.2M | $6.5M |
| Other current assets | $26,876 | $169,217 | $3.2M | $1.3M | $3.1M | $2.9M | $3.9M | $3.0M |
| Total current assets | $5.2M | $7.3M | $20.4M | $14.7M | $30.5M | $25.9M | $12.1M | $15.8M |
| Property, plant & equipment (net) | $0 | $136,678 | $255,216 | $397,649 | $524,954 | $643,785 | $69,837 | $0 |
| Goodwill & intangible assets | $0 | $3.2M | −$8.95B | −$25.27B | −$25.24B | $32.2M | $38.8M | $46.5M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $8.97B | $25.29B | $25.28B | $11.1M | $7.4M | $4.5M |
| Total assets | $5.2M | $10.6M | $33.8M | $32.4M | $67.4M | $69.9M | $58.4M | $66.9M |
| Liabilities | ||||||||
| Accounts payable | $83,883 | $2.3M | $1.7M | $1.8M | $4.6M | $5.6M | $3.8M | $1.8M |
| Short-term debt | — | $7.3M | $1.3M | $1.2M | $125,579 | $7.3M | $6.7M | $19.3M |
| Deferred revenue | $2.1M | $1.9M | $2.0M | — | −$125,579 | $28.9M | $30.2M | — |
| Total current liabilities | $2.3M | $18.0M | $10.8M | $7.1M | $31.0M | $41.9M | $41.1M | $38.5M |
| Long-term debt | $0 | $0 | $6.9M | $8.4M | $0 | $0 | $7.1M | $0 |
| Lease obligations | — | $137,656 | $262,679 | $262,678 | $405,018 | — | — | — |
| Other long-term liabilities | $0 | $75,223 | $3.7M | $262,678 | $865,018 | $10.5M | $2.2M | $30.0M |
| Total liabilities | $2.3M | $18.1M | $21.3M | $15.7M | $31.8M | $52.4M | $50.3M | $68.6M |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $4,228 | $1,053 | $298 | $208 | $2,068 | $971 | $29.1M | $1 |
| Retained earnings (deficit) | −$111.3M | −$113.2M | −$98.9M | −$90.7M | −$70.7M | −$61.7M | −$41.1M | −$1.7M |
| Accumulated other comprehensive income | — | — | −$409.0M | — | $0 | $0 | −$29.1M | — |
| Total shareholders' equity | $2.9M | −$7.5M | $12.5M | $16.7M | $35.5M | $17.5M | $8.0M | −$1.7M |
| Key figures | ||||||||
| Total debt | — | $7.4M | $8.3M | $9.9M | $405,018 | $7.8M | $13.7M | $47.2M |
| Net cash (debt) | — | −$3.7M | $5.1M | −$456,530 | $23.4M | $9.3M | −$11.6M | −$44.4M |
| Working capital | $2.9M | −$10.7M | $9.6M | $7.6M | −$437,381 | −$16.0M | −$29.0M | −$22.7M |
| Tangible book value | $2.9M | −$10.7M | $8.97B | $25.29B | $25.28B | −$14.7M | −$30.8M | −$48.2M |
| Current ratio | 2.25 | 0.40 | 1.89 | 2.08 | 0.99 | 0.62 | 0.29 | 0.41 |
| Quick ratio | 2.24 | 0.23 | 1.44 | 1.63 | 0.87 | 0.53 | 0.15 | 0.16 |
| Debt / equity | — | — | 0.66 | 0.59 | 0.01 | 0.45 | 1.71 | — |
| Equity / assets | 55.6% | −70.2% | 36.9% | 51.5% | 52.7% | 25.0% | 13.7% | −2.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $3.5M | $4.4M | $5.1M | $6.1M | $7.3M | $8.9M | $3.7M | $3.9M | $7.5M | $11.1M | $13.3M | $18.0M |
| Cash & equivalents | $3.5M | $4.4M | $5.1M | $6.1M | $7.3M | $8.9M | $3.7M | $3.9M | $7.5M | $11.1M | $13.3M | $18.0M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $443,555 | $416,076 | $1.9M | $1.8M | $2.0M | $2.2M | $3.0M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.3M | $3.0M | $3.1M | $2.8M | $2.7M | $1.6M | $2.5M |
| Other current assets | $57,124 | $42,000 | $26,876 | $63,202 | $75,342 | $3.8M | $169,217 | $1.8M | $1.9M | $2.1M | $3.2M | $987,120 |
| Total current assets | $3.5M | $4.4M | $5.2M | $6.1M | $7.4M | $14.5M | $7.3M | $10.7M | $14.0M | $17.9M | $20.4M | $24.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $21,719 | $136,678 | $143,749 | $177,587 | $216,973 | $255,216 | $292,362 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $443,555 | $3.2M | $6.8M | −$7.53B | $8.3M | $0 | $9.8M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $2.7M | $0 | $3.0M | $7.54B | $3.9M | $13.2M | $4.4M |
| Total assets | $3.5M | $4.4M | $5.2M | $6.1M | $7.4M | $17.6M | $10.6M | $20.7M | $25.2M | $30.3M | $33.8M | $38.9M |
| Liabilities | ||||||||||||
| Accounts payable | $97,282 | $133,304 | $83,883 | $421,142 | $970,025 | $756,703 | $2.3M | $1.6M | $791,091 | $2.1M | $1.7M | $1.4M |
| Short-term debt | — | — | — | — | — | $7.2M | $7.3M | $2.3M | $1.9M | $1.6M | — | $1.3M |
| Deferred revenue | — | $2.3M | — | $1.8M | $1.7M | $1.8M | $1.9M | $1.7M | $224,124 | $2.0M | — | $1.4M |
| Total current liabilities | $2.8M | $2.6M | $2.3M | $2.8M | $2.9M | $27.1M | $18.0M | $12.6M | $10.0M | $11.2M | $10.8M | $8.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.9M | $5.7M | $6.5M | $6.9M | $7.2M |
| Lease obligations | — | — | — | — | — | — | $137,656 | — | — | — | $262,679 | $300,153 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $57,590 | $75,223 | $91,832 | $309,756 | $1.9M | $3.7M | $16.5M |
| Total liabilities | $2.8M | $2.6M | $2.3M | $2.8M | $2.9M | $27.2M | $18.1M | $17.6M | $16.0M | $19.6M | $21.3M | $31.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $4,237 | $4,237 | — | $4,228 | $4,228 | $205 | $1,053 | $1,002 | $930 | $688 | — | $211 |
| Retained earnings (deficit) | −$113.2M | −$112.3M | −$111.3M | −$111.0M | −$110.0M | −$115.5M | −$113.2M | −$103.9M | −$101.7M | −$101.1M | −$98.9M | −$99.2M |
| Accumulated other comprehensive income | — | — | — | — | — | $0 | — | $0 | −$1.12B | −$906,979 | — | −$124,532 |
| Total shareholders' equity | $700,894 | $1.8M | $2.9M | $3.4M | $4.4M | −$9.6M | −$7.5M | $3.1M | $9.2M | $10.7M | $12.5M | $7.1M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | $7.2M | $7.4M | $7.3M | $7.7M | $8.1M | $6.9M | $8.7M |
| Net cash (debt) | — | — | — | — | — | $1.7M | −$3.7M | −$3.4M | −$281,865 | $2.9M | $6.5M | $9.3M |
| Working capital | $700,894 | $1.8M | $2.9M | $3.4M | $4.4M | −$12.7M | −$10.7M | −$1.8M | $4.0M | $6.7M | $9.6M | $16.4M |
| Tangible book value | $700,894 | $1.8M | $2.9M | $3.4M | $4.4M | −$10.0M | −$10.7M | −$3.7M | $7.54B | $2.4M | $12.5M | −$2.7M |
| Book value per share | $0.01 | $0.04 | $0.07 | $0.08 | $0.17 | — | — | $0.32 | — | — | — | — |
| Shares outstanding | 47.4M | 46.2M | 42.3M | 42.3M | 25.9M | — | — | 9.8M | — | — | — | — |
| Current ratio | 1.25 | 1.68 | 2.25 | 2.22 | 2.51 | 0.53 | 0.40 | 0.85 | 1.40 | 1.60 | 1.89 | 3.02 |
| Quick ratio | 1.23 | 1.66 | 2.24 | 2.20 | 2.48 | 0.35 | 0.23 | 0.47 | 0.93 | 1.16 | 1.44 | 2.59 |
| Debt / equity | — | — | — | — | — | — | — | 2.35 | 0.84 | 0.76 | 0.55 | 1.23 |
| Equity / assets | 19.8% | 40.3% | 55.6% | 54.9% | 60.1% | −54.4% | −70.2% | 15.1% | 36.5% | 35.3% | 36.9% | 18.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 15, 2026); data from EODHD.
PTPI financial position
At the end of fiscal 2025 (December 31, 2025), Petros Pharmaceuticals had total assets of $5.2 million (down 51.4% from a year earlier), total liabilities of $2.3 million and shareholders' equity of $2.9 million. Its current ratio was 2.25. In the latest quarter (ended June 30, 2026) total assets were $3.5 million and equity $0.7 million.
Related: PTPI income statement, PTPI cash flow statement, PTPI key metrics. See the PTPI stock overview for the latest quote and news.
PTPI balance sheet FAQ
What are Petros Pharmaceuticals's total assets?
Petros Pharmaceuticals reported total assets of $5.2 million at the end of fiscal 2025 (December 31, 2025), compared with $10.6 million a year earlier.
How much cash does Petros Pharmaceuticals have?
Petros Pharmaceuticals held $5.1 million in cash and short-term investments at the end of fiscal 2025.
What is Petros Pharmaceuticals's book value?
Petros Pharmaceuticals's shareholders' equity (book value) was $2.9 million at the end of fiscal 2025.
What is Petros Pharmaceuticals's current ratio?
Petros Pharmaceuticals had current assets of $5.2 million and current liabilities of $2.3 million, a current ratio of 2.25 (it can cover its short-term obligations).